Referenzen Vorgehen bei S. aureus-Bakteriämie

1) Mortalität der S. aureus-Bakteriämie

• Nambiar, K., Seifert, H., Rieg, S., Kern, W. V., Scarborough, M., Gordon, N. C., Kim, H. B., Song, K. H., Tilley, R., Gott, H., Liao, C. H., Edgeworth, J., Nsutebu, E., López-Cortés, L. E., Morata, L., Walker, A. S., Thwaites, G., Llewelyn, M. J., Kaasch, A. J.; International Staphylococcus aureus collaboration (ISAC) study group (with linked authorship to members in the Acknowledgements) and the ESCMID Study Group for Bloodstream Infections and Sepsis (ESGBIS) (2018). Survival following Staphylococcus aureus bloodstream infection: A prospective multinational cohort study assessing the impact of place of care. J Infect., 77(6):516-525. doi: 10.1016/j.jinf.2018.08.015. Epub 2018 Sep 1. PMID: 30179645.
• Thwaites, G. E., Scarborough, M., Szubert, A., Nsutebu, E., Tilley, R., Greig, J., Wyllie, S. A., Wilson, P., Auckland, C., Cairns, J., Ward, D., Lal, P., Guleri, A., Jenkins, N., Sutton, J., Wiselka, M., Armando, G. R., Graham, C., Chadwick, P. R., Barlow, G., Gordon, N. C., Young, B., Meisner, S., McWhinney, P., Price, D. A., Harvey, D., Nayar, D., Jeyaratnam, D., Planche, T., Minton, J., Hudson, F., Hopkins, S., Williams, J., Török, M. E., Llewelyn, M. J., Edgeworth, J. D., Walker, A. S.; United Kingdom Clinical Infection Research Group (UKCIRG) (2018). Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet., 391(10121):668-678. doi: 10.1016/S0140-6736(17)32456-X. Epub 2017 Dec 14. PMID: 29249276; PMCID: PMC5820409.
• Kimmig, A., Weis, S., Hagel, S., Forstner, C., Kesselmeier, M., Pletz, M. W. (2018). Infektiologische Konsile bei Patienten mit Staphylococcus-aureus-Bakteriämie – eine retrospektive Beobachtungsstudie am Universitätsklinikum Jena [Infectious Disease Consultations in Patients with Staphylococcus Aureus Bacteraemia - a Retrospective Observational Study at Jena University Hospital]. Dtsch Med Wochenschr., 143(21):e179-e187. German. doi: 10.1055/a-0653-7826. Epub 2018 Aug 31. Erratum in: Dtsch Med Wochenschr., 143(21):e2. PMID: 30170325.
• Vogel, M., Schmitz, R. P., Hagel, S., Pletz, M. W., Gagelmann, N., Scherag, A., Schlattmann, P., Brunkhorst, F. M. (2016). Infectious disease consultation for Staphylococcus aureus bacteremia - A systematic review and meta-analysis. J Infect., 72(1):19-28. doi: 10.1016/j.jinf.2015.09.037. Epub 2015 Oct 9. PMID: 26453841.

 2) Indikationen für die transösophageale Echokardiographie

• Kaasch, A. J., Fowler, V. G. Jr., Rieg, S., Peyerl-Hoffmann, G., Birkholz, H., Hellmich, M., Kern, W. V., Seifert, H. (2011). Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia. Clin Infect Dis., 53(1):1-9. doi: 10.1093/cid/cir320. PMID: 21653295; PMCID: PMC3149212.
• Khatib, R., Sharma, M. (2013). Echocardiography is dispensable in uncomplicated Staphylococcus aureus bacteremia. Medicine (Baltimore). 92(3):182-188. doi: 10.1097/MD.0b013e318294a710. PMID: 23619238; PMCID: PMC4553989.
• Tubiana, S., Duval, X., Alla, F., Selton-Suty, C., Tattevin, P., Delahaye, F., Piroth, L., Chirouze, C., Lavigne, J. P., Erpelding, M. L., Hoen, B., Vandenesch, F., Iung, B., Le Moing, V.; VIRSTA/AEPEI Study Group (2016). The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia. J Infect., 72(5):544-53. doi: 10.1016/j.jinf.2016.02.003. Epub 2016 Feb 22. PMID: 26916042.
• Salvador, V. B., Chapagain, B., Joshi, A., Brennessel, D. J. (2017). Clinical Risk Factors for Infective Endocarditis in Staphylococcus aureus Bacteremia. Tex Heart Inst J. 44(1):10-15. doi: 10.14503/THIJ-15-5359. PMID: 28265207; PMCID: PMC5317353.

3) Substanzauswahl und Dosierung bei der Staphylococcus aureus-Bakteriämie

• Weis, S., Kesselmeier, M., Davis, J. S., Morris, A. M., Lee, S., Scherag, A., Hagel, S., Pletz, M. W. (2019). Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 25(7):818-827. doi: 10.1016/j.cmi.2019.03.010. Epub 2019 Mar 27. PMID: 30928559.
• Paul, M., Zemer-Wassercug, N., Talker, O., Lishtzinsky, Y., Lev, B., Samra, Z., Leibovici, L., Bishara, J. (2011). Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect. 17(10):1581-6. doi: 10.1111/j.1469-0691.2010.03425.x. Epub 2010 Dec 14. PMID: 21073629.
• Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., J Rybak, M., Talan, D. A., Chambers, H. F.; Infectious Diseases Society of America (2011). Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 52(3):e18-55. doi: 10.1093/cid/ciq146. Epub 2011 Jan 4. Erratum in: Clin Infect Dis. 2011 Aug 1;53(3):319. PMID: 21208910.

4) Leitlinien der Staphylococcus aureus-Bakteriämie

• Minter, D. J., Appa, A., Chambers, H. F., Doernberg, S. B. (2023). Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical Practice. Clin Infect Dis. 77(11):e57-e68. doi: 10.1093/cid/ciad500. PMID: 37950887.
• Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., J Rybak, M., Talan, D. A., Chambers, H. F. (2011). Infectious Diseases Society of America. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 52(3):e18-55. doi: 10.1093/cid/ciq146. Epub 2011 Jan 4. Erratum in: Clin Infect Dis. 2011 Aug 1;53(3):319. PMID: 21208910.
• Delgado, V., Ajmone Marsan, N., de Waha, S., Bonaros, N., Brida, M., Burri, H., Caselli, S., Doenst, T., Ederhy, S., Erba, P. A., Foldager, D., Fosbøl, E. L., Kovac, J., Mestres, C. A., Miller, O. I., Miro, J.M., Pazdernik, M., Pizzi, M. N., Quintana, E., Rasmussen, T.B., Ristić, A.D., Rodés-Cabau, J., Sionis, A., Zühlke, L. J., Borger, M.A.; ESC Scientific Document Group (2023). 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 44(39):3948-4042. doi: 10.1093/eurheartj/ehad193. Erratum in: Eur Heart J. 2023 Sep 20;: Erratum in: Eur Heart J. 2024 Jan 1;45(1):56. PMID: 37622656.
• Blomström-Lundqvist, C., Traykov, V., Erba, P. A., Burri, H., Nielsen, J. C., Bongiorni, M. G., Poole, J., Boriani, G., Costa, R., Deharo, J. C., Epstein, L. M., Saghy, L., Snygg-Martin, U., Starck, C., Tascini, C., Strathmore, N.; ESC Scientific Document Group (2020). European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 22(4):515-549. doi: 10.1093/europace/euz246. PMID: 31702000; PMCID: PMC7132545.